These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12763519)

  • 41. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Androgen therapy in women: for whom and when.
    Pluchino N; Carmignani A; Cubeddu A; Santoro A; Cela V; Errasti T
    Arch Gynecol Obstet; 2013 Oct; 288(4):731-7. PubMed ID: 23912530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells.
    Sanchez WY; de Veer SJ; Swedberg JE; Hong EJ; Reid JC; Walsh TP; Hooper JD; Hammond GL; Clements JA; Harris JM
    Endocrinology; 2012 Jul; 153(7):3179-89. PubMed ID: 22547569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgen insufficiency in women.
    Braunstein GD
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S109-17. PubMed ID: 16631401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Androgen replacement therapy in androgen-deficient women with hypopituitarism.
    Zang H; Davis SR
    Drugs; 2008; 68(15):2085-93. PubMed ID: 18840000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
    Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen therapy in women: what we think we know.
    Drillich A; Davis SR
    Exp Gerontol; 2007 Jun; 42(6):457-62. PubMed ID: 17407803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating bioactive androgens in midlife women.
    Chen J; Sowers MR; Moran FM; McConnell DS; Gee NA; Greendale GA; Whitehead C; Kasim-Karakas SE; Lasley BL
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4387-94. PubMed ID: 16940455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.
    Panzer C; Wise S; Fantini G; Kang D; Munarriz R; Guay A; Goldstein I
    J Sex Med; 2006 Jan; 3(1):104-13. PubMed ID: 16409223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex hormone-binding globulin is associated with androgen deficiency features independently of total testosterone.
    Rastrelli G; Corona G; Cipriani S; Mannucci E; Maggi M
    Clin Endocrinol (Oxf); 2018 Apr; 88(4):556-564. PubMed ID: 29235134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
    Penttilä TL; Koskinen P; Penttilä TA; Anttila L; Irjala K
    Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.
    Traish AM; Vignozzi L; Simon JA; Goldstein I; Kim NN
    Sex Med Rev; 2018 Oct; 6(4):558-571. PubMed ID: 29631981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism.
    Cumming DC; Wall SR
    J Clin Endocrinol Metab; 1985 Nov; 61(5):873-6. PubMed ID: 4044776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.